Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 20;2(1):63.
doi: 10.1186/2191-219X-2-63.

Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner

Affiliations

Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner

Marc C Huisman et al. EJNMMI Res. .

Abstract

Background: Positron emission tomography (PET) allows for the measurement of cerebral blood flow (CBF; based on [15O]H2O) and cerebral metabolic rate of glucose utilization (CMRglu; based on [18 F]-2-fluoro-2-deoxy-d-glucose ([18 F]FDG)). By using kinetic modeling, quantitative CBF and CMRglu values can be obtained. However, hardware limitations led to the development of semiquantitive calculation schemes which are still widely used. In this paper, the analysis of CMRglu and CBF scans, acquired on a current state-of-the-art PET brain scanner, is presented. In particular, the correspondence between nonlinear as well as linearized methods for the determination of CBF and CMRglu is investigated. As a further step towards widespread clinical applicability, the use of an image-derived input function (IDIF) is investigated.

Methods: Thirteen healthy male volunteers were included in this study. Each subject had one scanning session in the fasting state, consisting of a dynamic [15O]H2O scan and a dynamic [18 F]FDG PET scan, acquired at a high-resolution research tomograph. Time-activity curves (TACs) were generated for automatically delineated and for manually drawn gray matter (GM) and white matter regions. Input functions were derived using on-line arterial blood sampling (blood sampler derived input function (BSIF)). Additionally, the possibility of using carotid artery IDIFs was investigated. Data were analyzed using nonlinear regression (NLR) of regional TACs and parametric methods.

Results: After quality control, 9 CMRglu and 11 CBF scans were available for analysis. Average GM CMRglu values were 0.33 ± 0.04 μmol/cm3 per minute, and average CBF values were 0.43 ± 0.09 mL/cm3 per minute. Good correlation between NLR and parametric CMRglu measurements was obtained as well as between NLR and parametric CBF values. For CMRglu Patlak linearization, BSIF and IDIF derived results were similar. The use of an IDIF, however, did not provide reliable CBF estimates.

Conclusion: Nonlinear regression analysis, allowing for the derivation of regional CBF and CMRglu values, can be applied to data acquired with high-spatial resolution current state-of-the-art PET brain scanners. Linearized models, applied to the voxel level, resulted in comparable values. CMRglu measurements do not require invasive arterial sampling to define the input function.

Trial registration: ClinicalTrials.gov NCT00626080.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation between Patlak- and NLR-derived Kivalues. Data of all 16 gray matter regions and a white matter brain region of nine healthy subjects are presented. Data points for each individual subject are shown with a separate symbol. The solid line indicates the line of identity.
Figure 2
Figure 2
Correlation of average Kivalues derived using parametric and regional Patlak analyses. Data of all 16 total gray matter regions and a white matter brain region are presented for nine subjects. Parametric values represent the mean of all voxels within an ROI. The solid line indicates the line of identity. Results for both images without smoothing (black dots) and those smoothed with a 6-mm Gaussian filter (white dots) are shown.
Figure 3
Figure 3
Representative parametric images of a single subject. The CBF image (upper panel) and the CMRglu image (lower panel) of the same subject are presented. The parametric CBF image was generated after smoothing with a 6-mm Gaussian filter.
Figure 4
Figure 4
Correlation of CBF values derived using parametric (basis function method) and regional (NLR) analyses. Data of 16 gray matter regions and a white matter region are shown for 11 subjects. Parametric values represent the mean of all voxels within an ROI. Data points for each individual subject are shown with a separate symbol. The solid line indicates the line of identity.
Figure 5
Figure 5
Correlation between IDIF- and BSIF-based NLR-derived Kivalues. The correlation is for 16 gray matter regions and a white matter region. Data points for each individual subject (n = 9) are shown with the same symbol. The solid line indicates the line of identity.
Figure 6
Figure 6
Correlation between IDIF- and BSIF-based Patlak-derived Kivalues. The correlation is for 16 gray matter regions and a white matter region. Data points for each individual subject (n = 9) are shown with the same symbol. The solid line indicates the line of identity.

References

    1. Lammertsma AA, Brooks DJ, Frackowiak RS, Beaney RP, Herold S, Heather JD, Palmer AJ, Jones T. Measurement of glucose utilization with [18 F]2-fluoro-2-deoxy-D-glucose: a comparison of different analytical methods. J Cereb Blood Flow Metab. 1987;7:161–172. doi: 10.1038/jcbfm.1987.39. - DOI - PubMed
    1. Schmidt KC, Lucignani G, Sokoloff L. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination. J Nucl Med. 1996;37:394–399. - PubMed
    1. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol. 1980;238:E69–E82. - PubMed
    1. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6:371–388. doi: 10.1002/ana.410060502. - DOI - PubMed
    1. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Som P, Sokoloff L. The [18 F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res. 1979;44:127–137. doi: 10.1161/01.RES.44.1.127. - DOI - PubMed

Associated data